Literature DB >> 17122726

Pediatric multiple sclerosis.

Tanuja Chitnis1.   

Abstract

BACKGROUND: It is becoming ever more recognized that multiple sclerosis (MS) occurs in children and adolescents. Although early-onset MS is a variant in the spectrum of MS phenotypes, the diagnosis and management of MS in children poses a unique set of challenges for the clinician. Moreover, it is increasingly clear that these patients require specialized care, which includes a closely monitored medication program, physical therapy, cognitive and educational evaluation and intervention, and psychosocial support both for the patient and family. REVIEW
SUMMARY: The goal of this article is to familiarize the clinician with the clinical and MRI features of pediatric multiple sclerosis and to summarize what is currently known about the clinical disease course. This article highlights important entities in the differential diagnosis of pediatric MS and discusses management strategies based on current literature.
CONCLUSION: Children and adolescents with MS comprise a small but important subset of MS patients who require a multidisciplinary care approach. Additional multicenter studies are required to explore the effects of disease and treatments on physical, psychosocial, educational, and developmental parameters.

Entities:  

Mesh:

Year:  2006        PMID: 17122726     DOI: 10.1097/01.nrl.0000250946.87145.cf

Source DB:  PubMed          Journal:  Neurologist        ISSN: 1074-7931            Impact factor:   1.398


  5 in total

1.  Tract-based analysis of callosal, projection, and association pathways in pediatric patients with multiple sclerosis: a preliminary study.

Authors:  M S Vishwas; T Chitnis; R Pienaar; B C Healy; P E Grant
Journal:  AJNR Am J Neuroradiol       Date:  2009-10-22       Impact factor: 3.825

2.  Pediatric multiple sclerosis.

Authors:  Yashma Patel; Vikram Bhise; Lauren Krupp
Journal:  Ann Indian Acad Neurol       Date:  2009-10       Impact factor: 1.383

Review 3.  Disease-modifying therapy of pediatric multiple sclerosis.

Authors:  Tanuja Chitnis
Journal:  Neurotherapeutics       Date:  2013-01       Impact factor: 7.620

4.  Clinical and pharmacological aspects of inflammatory demyelinating diseases in childhood: an update.

Authors:  Alberto Spalice; Pasquale Parisi; Laura Papetti; Francesco Nicita; Fabiana Ursitti; Francesca Del Balzo; Enrico Properzi; Alberto Verrotti; Martino Ruggieri; Paola Iannetti
Journal:  Curr Neuropharmacol       Date:  2010-06       Impact factor: 7.363

5.  Diagnostic criteria for pediatric multiple sclerosis.

Authors:  Jennifer P Rubin; Nancy L Kuntz
Journal:  Curr Neurol Neurosci Rep       Date:  2013-06       Impact factor: 5.081

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.